Navigation Links
Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
Date:6/1/2008

please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strategic goals, drug development plans, results of clinical trials and the potential safety and efficacy of its products in development. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre-clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2008 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are t
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
2. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
3. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
4. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
5. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
6. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
7. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
8. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
11. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire-FirstCall/--NeurocrineBiosciences,Inc.(Na...tandChiefExecutiveOfficerofNeurocrineBiosciences,w...reConferenceinNewYork. ,, Thelivepresentationta...e(ET)/1:30p.m.PacificTime(PT).Thepresentationwillb...,swebsiteat http://www.neurocrine.com . ,, Ifyo...
(Date:11/24/2009).../PRNewswire-FirstCall/--ZimmerHoldings,Inc.(NYSE: ...the21stAnnualPiperJaffrayHealthCareConferenceinNew...e. ,, Alivewebcastofthepresentationcanbeaccesse...stor.zimmer.com .Thewebcastwillbearchivedforreplay..., Foundedin1927andheadquarteredinWarsaw,Indiana,...
(Date:11/24/2009)...ass.,Nov.24/PRNewswire/--VisageImaging®,Inc.,...llbeintroducingVisage®7,thecompany,snewgenera...nceoftheRadiologicSocietyofNorthAmerica(RSNA),Nove...174;7deliversnewlevelsofversatilityandperformancet...erringphysicians.TheVisage7UniversalViewerisasingl...
Breaking Medicine Technology:Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X 2TOMA LECHE for Healthy Strong Mom 26amp 3B Baby 61547 1TOMA LECHE for Healthy Strong Mom 26amp 3B Baby 61547 2TOMA LECHE for Healthy Strong Mom 26amp 3B Baby 61547 3Shopko Announces Launch of e Commerce Platform 61542 1Shopko Announces Launch of e Commerce Platform 61542 2SIRO Clinpharm Collaborates with Mediscis Broadens Early Phase Drug Development Expertise 6344 1SIRO Clinpharm Collaborates with Mediscis Broadens Early Phase Drug Development Expertise 6344 2
(Date:11/24/2009)... University School of Medicine (BUSM) and the Bost...ve identified a number of proteins whose activatio...rmal cells with almost 97 percent accuracy. In add...putational strategy to analyze this data and speci...r circuits) that are active in cancer and "dormant...
(Date:11/24/2009)...ire/--Quantros,aleadinghealthcareanalyticsanddecis...aythatithaslicensedintellectualpropertyandassociat...egrationintoQuantros,suiteofsafetyandriskmanagemen...withintheSRMproductfamilywillenableautomatedsafety...nofahealthcareprovider,sintegratedadministrativeda...
(Date:11/24/2009)... recruiting firm LocumTenens.com, a leading provid...announce its agreement with VHA Inc., a national h... tenens assignments. , Al...an recruiting firm LocumTenens.com , a leading p...d to announce its agreement with VHA Inc., a natio...
(Date:11/24/2009)...ire/--NIP,Inc.todayannouncedtheacquisitionofRetire...cutivecompensationandbenefitplanprovidersheadquart...sAngeles,Milwaukee,Boston,ChicagoandAtlanta.RCGwas...heexecutivebenefitsindustry. ,, "Weareexcitedto...antmarketpresence,"statesBillPollock,ChairmanandFo...
(Date:11/24/2009)...RNewswire/--Bionorica,aninternationalcompanypionee...aytheavailabilityofneweducationalresourcesforparen...heeton"StayingNaturallyHealthyduringtheHolidays,"t...leonthecompany,swebsiteat www.bionoricausa.com . ,...iontotheNaturalMomstipsheets,withcontentcontribute...
Breaking Medicine News(10 mins):Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2
...his week in The,Wall Street Journal said Merck & C... blockbuster drug Vytorin under wraps for more tha...t on to say the study - which found,Vytorin was no...e scientific,publications process, organizations a...
...ess State Regulations, JERICHO, N.Y., March 26 H... leading provider of online healthcare compliance ...ship with University,HealthSystem Consortium (UHC)...hat are appropriate for clinical and non-,clinical...
...al Resources & Assessment Tools To Help ...W YORK, March 26 EnergyNow!, an alliance,comprise... and fitness,technology fields, today announced th...on D.C. combat childhood,obesity through a results...
...nning Mind Fitness Company, WASHINGTON, March 26 ...iFit, Ltd., the company that uses the latest scien...t will enhance human cognitive,performance and hea...., "CogniFit is always looking to work with indiv...
...recipients report lower health-related quality of ...y, compared to reports from the parents of healthy...fall within the normal range. These findings are p...ldren account for up to 15 percent of liver transp...
...ar NY HR Week(TM) Event; Early Bird R...Pa., March 26 HR professionals attending Human,Re...TM) Conference, being,held April 15 - 17, 2008, wi...e Hilton Hotel, easily accessible in New,York City...
Other Medicine News:Health News:Best Practice Database: Complimentary Excerpt of Scientific Publications Strategy Study 2Health News:HCCS Partners With UHC to Deliver Cultural Competency Courses 2Health News:HCCS Partners With UHC to Deliver Cultural Competency Courses 3Health News:EnergyNow! Announces New Grant Funding to Combat Childhood Obesity 2Health News:EnergyNow! Announces New Grant Funding to Combat Childhood Obesity 3Health News:CogniFit to Work With Gloria Cavanaugh, Former ASA President 2Health News:Study shows lifetime effects of pediatric liver transplants 2Health News:Next Month's HR in Healthcare(TM) Conference Promises to be Educational Destination for the Healthcare Industry's Senior HR Practitioners 2Health News:Next Month's HR in Healthcare(TM) Conference Promises to be Educational Destination for the Healthcare Industry's Senior HR Practitioners 3
Viscous Infusion Cannula 6mm
Infusion Cannula 6mm
Infusion Cannula 4mm
DCR Set
Medicine Products: